EirGenix Inc. (TPE:6589)

EirGenix Statistics

Total Valuation

EirGenix has a market cap or net worth of TWD 22.33 billion. The enterprise value is 20.85 billion.

Market Cap	22.33B
Enterprise Value	20.85B

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

EirGenix has 302.20 million shares outstanding. The number of shares has decreased by -0.57% in one year.

Current Share Class	302.20M
Shares Outstanding	302.20M
Shares Change (YoY)	-0.57%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	1.42%
Owned by Institutions (%)	7.35%
Float	192.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.86
PB Ratio	2.65
P/TBV Ratio	2.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.54
EV / Sales	22.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.64

Financial Position

The company has a current ratio of 7.56, with a Debt / Equity ratio of 0.17.

Current Ratio	7.56
Quick Ratio	5.98
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-0.79
Interest Coverage	-97.57

Financial Efficiency

Return on equity (ROE) is -7.90% and return on invested capital (ROIC) is -4.63%.

Return on Equity (ROE)	-7.90%
Return on Assets (ROA)	-4.42%
Return on Invested Capital (ROIC)	-4.63%
Return on Capital Employed (ROCE)	-7.61%
Revenue Per Employee	936,175
Profits Per Employee	-705,764
Employee Count	1,000
Asset Turnover	0.09
Inventory Turnover	1.38

Taxes

In the past 12 months, EirGenix has paid 1.78 million in taxes.

Income Tax	1.78M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.26% in the last 52 weeks. The beta is 0.55, so EirGenix's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-20.26%
50-Day Moving Average	70.04
200-Day Moving Average	66.87
Relative Strength Index (RSI)	54.46
Average Volume (20 Days)	1,638,426

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EirGenix had revenue of TWD 936.18 million and -705.76 million in losses. Loss per share was -2.33.

Revenue	936.18M
Gross Profit	168.18M
Operating Income	-748.68M
Pretax Income	-703.98M
Net Income	-705.76M
EBITDA	-524.81M
EBIT	-748.68M
Loss Per Share	-2.33

Balance Sheet

The company has 2.90 billion in cash and 1.42 billion in debt, giving a net cash position of 1.49 billion or 4.92 per share.

Cash & Cash Equivalents	2.90B
Total Debt	1.42B
Net Cash	1.49B
Net Cash Per Share	4.92
Equity (Book Value)	8.44B
Book Value Per Share	27.93
Working Capital	3.68B

Cash Flow

In the last 12 months, operating cash flow was -403.12 million and capital expenditures -1.39 billion, giving a free cash flow of -1.79 billion.

Operating Cash Flow	-403.12M
Capital Expenditures	-1.39B
Free Cash Flow	-1.79B
FCF Per Share	-5.92

Margins

Gross margin is 17.96%, with operating and profit margins of -79.97% and -75.39%.

Gross Margin	17.96%
Operating Margin	-79.97%
Pretax Margin	-75.20%
Profit Margin	-75.39%
EBITDA Margin	-56.06%
EBIT Margin	-79.97%
FCF Margin	n/a

Dividends & Yields

EirGenix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.57%
Shareholder Yield	0.57%
Earnings Yield	-3.16%
FCF Yield	-8.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EirGenix has an Altman Z-Score of 6.91 and a Piotroski F-Score of 1.

Altman Z-Score	6.91
Piotroski F-Score	1